Yardi® Aspire is thrilled to introduce its self-service course catalog, a new feature that allows Aspire Plus and Aspire ...
SDIRA Wealth, a leading full-service Build-to-Rent developer, is excited to announce their support and partnership with the ...
At HUAWEI CONNECT 2024, the Huawei Cloud Stack Roundtable for Global Government CIOs, with the theme, "Dive into Cloud and ...
Scottsdale, AZ, RONN Inc announced that the Company has officially forged a new expanded agreement with Hydrogen Energy Systems Inc., allowing RONN exclusivity on their patented low-pressure hydrogen ...
The DJS Law Group alerts investors of an investigation focusing on Franklin Resources, Inc. ("Franklin" or "the Company") for potential violations of the securities ...
Net income for the U.S. life/annuity (L/A) insurance industry increased by 7.1% in the first half of 2024 over the same prior-year period to $14.1 billion, driven largely by lower realized capital ...
Stryker , a global leader in medical technologies, announced today that it has completed the acquisition of NICO Corporation, a privately held company providing a systematic approach to minimally ...
As macro-economic challenges mount, Global Business Services (GBS) organizations are at a pivotal juncture. A new study by Zinnov, a global management consulting firm, and ProHance, a productivity ...
Exiger, the market-leading supply chain and third-party risk AI company, is a top-ranked vendor in Third Party Risk Management (TPRM) and Supply Chain Risk Management (SCRM) Platform Technologies ...
TransDigm Group Incorporated ("TransDigm Group") today announced that its Board of Directors has authorized and declared a special cash dividend of $75.00 on each outstanding share of common stock and ...
Center for the Future of Arizona (CFA) today shares an update from its latest 2024 Arizona Voters' Agenda survey, with insights into voters' views on education issues. Arizonans are voicing clear ...
Pfizer Inc. and BioNTech SE today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization for the ...